Telemedicine cardiovascular risk reduction in veterans
S Dee Melnyk, Leah L Zullig, Felicia McCant, Susanne Danus, Eugene Oddone, Lori Bastian, Maren Olsen, Karen M Stechuchak, David Edelman, Susan Rakley, Miriam Morey, Hayden B Bosworth, S Dee Melnyk, Leah L Zullig, Felicia McCant, Susanne Danus, Eugene Oddone, Lori Bastian, Maren Olsen, Karen M Stechuchak, David Edelman, Susan Rakley, Miriam Morey, Hayden B Bosworth
Abstract
Background: Patients with co-occurrence of hypertension, hyperlipidemia, and diabetes have an increased risk of cardiovascular disease (CVD) events. Comprehensive programs addressing both tailored patient self-management and pharmacotherapy are needed to address barriers to optimal cardiovascular risk reduction. We are examining a Clinical pharmacy specialist-, telephone-administered intervention, relying on home monitoring, with a goal of providing tailored medication and behavioral intervention to Veterans with CVD risk.
Methods: Randomized controlled trial including patients with hypertension (blood pressure >150/100 mm Hg) or elevated low density liporotein (>130 mg/dL). Longitudinal changes in CVD risk profile and improvement in health behaviors over time will be examined.
Conclusion: Given the national prevalence of CVD and the dismal rates of risk factor control, intensive but easily disseminated interventions are required to treat this epidemic. This study will be an important step in testing the effectiveness of a behavioral and medication intervention to improve CVD control among Veterans.
Trial registration: ClinicalTrials.gov NCT01142908.
Published by Mosby, Inc.
Figures
Source: PubMed